Oppenheimer & Co. Inc. Sells 1,528 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

Oppenheimer & Co. Inc. trimmed its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 3.0% during the 3rd quarter, Holdings Channel reports. The firm owned 49,713 shares of the real estate investment trust’s stock after selling 1,528 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Omega Healthcare Investors were worth $2,023,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Allspring Global Investments Holdings LLC increased its holdings in shares of Omega Healthcare Investors by 93.7% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 4,803 shares of the real estate investment trust’s stock worth $152,000 after buying an additional 2,324 shares during the last quarter. Sei Investments Co. raised its position in Omega Healthcare Investors by 3.4% during the first quarter. Sei Investments Co. now owns 119,138 shares of the real estate investment trust’s stock valued at $3,774,000 after purchasing an additional 3,909 shares in the last quarter. State Board of Administration of Florida Retirement System raised its position in Omega Healthcare Investors by 3.4% during the first quarter. State Board of Administration of Florida Retirement System now owns 255,348 shares of the real estate investment trust’s stock valued at $8,087,000 after purchasing an additional 8,491 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in Omega Healthcare Investors by 2.2% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 149,951 shares of the real estate investment trust’s stock worth $4,749,000 after purchasing an additional 3,184 shares during the last quarter. Finally, Mitsubishi UFJ Trust & Banking Corp boosted its holdings in shares of Omega Healthcare Investors by 1.5% in the 1st quarter. Mitsubishi UFJ Trust & Banking Corp now owns 38,719 shares of the real estate investment trust’s stock worth $1,232,000 after purchasing an additional 573 shares in the last quarter. 65.25% of the stock is owned by hedge funds and other institutional investors.

Omega Healthcare Investors Stock Up 0.7 %

NYSE OHI opened at $40.03 on Friday. Omega Healthcare Investors, Inc. has a 1 year low of $27.53 and a 1 year high of $44.42. The stock has a market capitalization of $10.81 billion, a PE ratio of 29.42, a PEG ratio of 1.25 and a beta of 0.99. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 6.48. The business’s 50-day moving average is $40.66 and its 200 day moving average is $36.66.

Omega Healthcare Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were given a $0.67 dividend. The ex-dividend date was Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.69%. Omega Healthcare Investors’s dividend payout ratio is currently 197.06%.

Analysts Set New Price Targets

A number of analysts recently weighed in on the company. Truist Financial boosted their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research report on Wednesday, September 4th. Mizuho lowered shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and boosted their price objective for the stock from $34.00 to $35.00 in a report on Thursday, July 25th. Wells Fargo & Company reiterated an “overweight” rating and issued a $43.00 target price (up previously from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. BMO Capital Markets boosted their price target on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a research note on Monday, October 7th. Finally, Berenberg Bank started coverage on Omega Healthcare Investors in a research note on Friday, October 18th. They set a “buy” rating and a $45.00 price objective on the stock. Seven research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Omega Healthcare Investors has an average rating of “Hold” and an average target price of $40.00.

Insider Activity

In related news, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the sale, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. The trade was a 36.19 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the transaction, the chief financial officer now owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This trade represents a 10.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.37% of the company’s stock.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.